Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Pharmaceuticals (Basel)
; 16(3)2023 Mar 21.
Article
in En
| MEDLINE
| ID: mdl-36986565
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Health_economic_evaluation
/
Observational_studies
Aspects:
Implementation_research
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: